Boston Scientific Corporation is a global leader in developing and manufacturing medical devices that cater to a wide range of interventional medical specialties. With a focus on improving patient outcomes, it offers innovative solutions for gastrointestinal, pulmonary, urological, neurological, and cardiovascular conditions. Its portfolio includes devices for diagnosing and treating coronary artery disease, heart rhythm disorders, and various forms of cancer. Founded in 1979 and based in Marlborough, Massachusetts, Boston Scientific is dedicated to transforming lives through medical innovation.
Abbott Laboratories has shed billions in market value this year while the broader market climbed, yet one analyst on Wall Street sees a dramatically different story unfolding beneath the surface of the…
After a week of wild swings that rattled portfolios and left investors guessing, Wall Street analysts are already reshuffling their ratings on Friday morning, with some surprising cuts and upgrades across sectors…
Wall Street analysts are busy reshuffling their ratings ahead of the Fed meeting, with surprise double-upgrades, dramatic target cuts, and fresh initiations spanning surgical robots to cybersecurity. Find out which names made…
Pre-Market Stock Futures: Futures are trading lower on Thursday as new records are set almost daily, with the AI/Data center trade continuing to push stocks higher on Wednesday. All four major indices…
Pre-Market Stock Futures: Futures are trading modestly higher as we hit the midweek mark, and some buyers’ exhaustion likely played a role, as all the major indices finished lower on Tuesday. This…
Boston Scientific (NYSE:BSX | BSX Price Prediction) stock has taken a beating in 2026 after management cut full-year guidance on Wednesday. On Thursday, three major firms trimmed price targets while keeping bullish…
David Moadel Pre-Market Stock Futures: Futures are trading lower on this Thursday, but what a difference a month makes: 30 days ago, the worries over inflation and the spiraling situation in Iran were weighing…
Boston Scientific (NYSE: BSX | BSX Price Prediction) trades around $61, with analyst price targets ranging from $69 (conservative) to $124 (optimistic), implying substantial upside. Abbott Laboratories (NYSE: ABT) trades near $95…
Pre-Market Stock Futures: Futures are trading higher as shell-shocked traders and investors return to a holiday-shortened trading week, where all the major indices are approaching or already in correction territory (down 10%).…
Edwards Lifesciences (NYSE: EW | EW Price Prediction) and Boston Scientific (NYSE: BSX) both reported strong quarters, but the results reveal fundamentally different strategies in the heart device market. Edwards doubled down…
Live Updates Wednesday Wrap-up4:15pm ETThe Vanguard S&P 500 ETF closed Wednesday at a new all-time high of 582.93, up 0.7%. Otis Elevator Only Goes Down Today11:54am ETStill hungry for more earnings news?…
Here is a look at how shares of FuelCell Energy, Gilead Sciences, Starbucks and more have fared since their initial public offerings in 1992.
Friday's top analyst upgrades and downgrades included Analog Devices, Boston Scientific, CrowdStrike, Enphase Energy, Frontier, International Paper, Nike, Petrobras, Truist Financial and VICI Properties.
Tuesday's top analyst upgrades and downgrades included Academy Sports and Outdoors, Boston Scientific, Ciena, CrowdStrike, Emerson Electric, Kimco Realty, Nike, NovoCure and Zimmer Biomet.
Wednesday's top analyst upgrades and downgrades included Abbott Laboratories, Boston Scientific, ChargePoint, Coinbase Global, Dollar General, Equitrans Midstream, Ford, Hasbro, Johnson & Johnson, Kenvue and Medtronic.
